Earnings FeedTerminal

⌘K

Home/Insiders/Meyer Andrew Hollman

MA

SEC Insider//CIK 0001864159

Meyer Andrew Hollman

CIK 00018641591 companySAN DIEGO, CA

Transactions

8

Companies

1

Filings

1

CIK

0001864159

Recent Transactions

8 trades

Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2025-12-01$10.59/sh+3,333→ 88,307 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-12-01$32.85/sh−2,700→ 85,607 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-12-01$33.52/sh−633→ 84,974 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-12-01−3,333→ 114,768 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2025-12-01$10.59/sh+3,333→ 88,307 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-12-01$32.85/sh−2,700→ 85,607 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-12-01$33.52/sh−633→ 84,974 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-12-01−3,333→ 114,768 total

Companies

1

Janux Therapeutics, Inc.
Chief Business Officer
$JANX

Recent Filings

1

4
Meyer Andrew Hollman
Dec 3, 2025

Address

C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200

SAN DIEGO, CA, 92130

View on SEC.gov